Colon cancer continues to be one of the leading causes of mortality and morbidity
throughout the world despite the availability of reliable screening tools and effective …

The main therapeutic options for colorectal cancer are surgical resection and adjuvant
chemotherapy in non-metastatic disease. However, the evaluation of the overall adjuvant …

PURPOSE To develop recommendations for adjuvant therapy for patients with resected
stage II colon cancer. METHODS ASCO convened an Expert Panel to conduct a systematic …

Simple Summary In patients with stage III colon cancer, adjuvant chemotherapy with a
fluoropyrimidine combined with oxaliplatin reduces the risk of recurrence and mortality, with …

Simple Summary Stage II colon cancer is defined as an early stage of the tumor disease,
without the involvement of lymph nodes or distant organs. In this group of patients, surgery …

This study aimed to validate the prognostic value of Immunoscore (IS) in stage II colorectal
cancer (CRC), and explore the roles of IS and circulating tumor DNA (ctDNA) in the adjuvant …

Routine tumor-node-metastasis (TNM) staging of colorectal cancer is imperfect in predicting
survival due to tumor pathobiological heterogeneity and imprecise assessment of tumor …

Purpose Radiomics is a promising method for advancing imaging assessment in rectal
cancer. This review aims to describe the emerging role of radiomics in the imaging …

Aim The aim was to assess the benefit of adjuvant chemotherapy in high‐risk Stage II
colorectal cancer. Method A systematic literature review and meta‐analysis was performed …

Introduction Colorectal cancer (CRC) is the third most common and second most deadly
malignancy in the world with an estimated 1. 9 million cases and 0.9 million deaths in 2020 …